License Agreement by and between bluebird bio, Inc. and SIRION Biotech GmbH December 23, 2015License Agreement • February 21st, 2019 • Bluebird Bio, Inc. • Biological products, (no disgnostic substances) • New York
This License Agreement (this “Agreement”), effective as of December 23, 2015 (the “Effective Date”), is entered into by and between SIRION Biotech GmbH, a corporation organized under the laws of Germany (“SIRION”), and bluebird bio, Inc., a Delaware corporation (“Bluebird”). SIRION and Bluebird are referred to individually as a “Party” and collectively as the “Parties.”
Clinical and Commercial Supply Agreement Viral Vector Product by and between bluebird bio, Inc. and SAFC Carlsbad, Inc. November 27, 2017Supply Agreement • February 21st, 2019 • Bluebird Bio, Inc. • Biological products, (no disgnostic substances) • Massachusetts
This Clinical and Commercial Supply Agreement (this “Agreement”), executed as of November 27, 2017 and effective as of January 1, 2018 (the “Effective Date”), is entered into by and between:
Toll Manufacturing and Service Agreement by and between bluebird bio, Inc. and APCETH Biopharma GmbH November 18, 2016And Service Agreement • February 21st, 2019 • Bluebird Bio, Inc. • Biological products, (no disgnostic substances)
